DataMEDS AI begins trading on Nasdaq under new ticker symbol MEDS

DataMEDS AI, Inc. (NASDAQ: MEDS) began trading under its new stock symbol on the Nasdaq Capital Market on July 22, 2026, completing a corporate rebranding from its prior name Wellgistics Health, Inc. (NASDAQ: WGRX), according to a company press release.

The company describes itself as a Health IT firm operating an artificial intelligence platform called EinsteinRx™ and a blockchain-enabled smart contracts platform called PharmacyChain™. It also operates a mobile application called Health Lives Here and a supplement brand called Tollo Health.

Gerald Commissiong, Interim Co-CEO of DataMEDS, said the new ticker is "expected to help capture the attention and focus of the Health IT-focused investment community by immediately aligning the Company's mission of continually acquiring and analyzing data with the desired outcome of making the best treatment decisions."

As of the press release date, DataMEDS has 2,847,198 common shares outstanding. Stockholders holding approximately 1,533,930 shares, representing a majority of outstanding common shares, have entered into lock-up agreements restricting share sales for at least 90 days. There are 919,465 common shares deposited in the Depository Trust & Clearing Corporation available for trading. The company reports no debt or preferred equity securities currently convertible into free-trading common shares, and 80,826 cash warrants outstanding at a fixed exercise price of $35.00 per share.

The company stated it is focused on completing a previously disclosed series of acquisition and licensing transactions.

You May Also Be Interested In

• Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
• GE Aerospace and Magellan sign F414 engine MRO deal for Canada
• NovaGold to reincorporate in Delaware via arrangement with Paulson